ReviewAntioxidants (Basel, Switzerland)2025
Microalgae-Derived Peptides Targeting Lifestyle-Related Diseases: Discovery, Mechanisms, Structure-Activity Relationships, and Structural Modifications.
Review in Antioxidants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Use of an Alkaline Wastewater Stream to Increase the Initial pH of Whey and Recover a Microbial Biomass with High Protein Content.Foods (Basel, Switzerland) · 2026Article
- Recent Advances in NADES-Assisted Process Intensification Technologies for Sustainable Recovery of Microalgal Bioactives: Challenges and Future Prospectives.Marine drugs · 2026Review
- Algae-Derived Peptides as Functional Food Ingredients: Bioactivities, Processing Challenges, and Computational Design Strategies.Foods (Basel, Switzerland) · 2026Review
- Isolation, Characterization, and Antioxidant Activity of Peptides Derived fromFoods (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Microalgae are an emerging source of bioactive peptides with promising therapeutic potential against lifestyle-related diseases such as oxidative stress-related conditions, hypertension, diabetes, and obesity. While numerous studies have investigated the biological activities of microalgae-derived peptides, a comprehensive understanding of their structural features and structure-activity relationships remains limited. This review provides a detailed overview of current strategies used to discover bioactive peptides from microalgae, encompassing both conventional and computational approaches. Particular emphasis is placed on correlating identified peptide sequences with their reported biological activities to provide critical insights into the key structural motifs responsible for activity. Furthermore, recent advances in peptide modification techniques are discussed in the context of enhancing the bioactivity of microalgae-derived peptides. By integrating discovery strategies, structure-activity relationships, and emerging trends in peptide modification, this review highlights the potential of microalgae-derived peptides as next-generation therapeutic agents for managing lifestyle-related diseases and identifies opportunities for future research and clinical translation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.